Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 5/20 | 0.61 |
| ▸ | IL23R | Q5VWK5 | 8/20 | 0.57 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30276253 | 0.92 | GHSR (0.64) | GHSRIL23RKISS1R | |
| SCHEMBL29551293 | 0.92 | GHSR (0.64) | GHSRIL23RKISS1R | |
| SCHEMBL30276276 | 0.91 | GHSR (0.63) | GHSRIL23RKISS1R | |
| SCHEMBL30276219 | 0.89 | GHSR (0.61) | GHSRIL23R | |
| SCHEMBL30276201 | 0.89 | GHSR (0.60) | GHSRIL23R | |
| SCHEMBL29550892 | 0.89 | GHSR (0.62) | GHSRIL23RKISS1R | |
| SCHEMBL30276275 | 0.88 | GHSR (0.60) | GHSRIL23RKISS1R | |
| SCHEMBL30276259 | 0.88 | GHSR (0.60) | GHSRIL23RKISS1R | |
| SCHEMBL29359135 | 0.88 | KISS1R (0.62) | GHSRIL23RKISS1R | |
| SCHEMBL29565376 | 0.88 | GHSR (0.61) | GHSRIL23RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11261215-B2 | Somatostatin prodrugs | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2022-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11261215-B2 | Somatostatin prodrugs | VIP, SSTR4, SSTR5 | GHSR 18/4885IL23R 2061/4885KISS1R 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.